Funobactam

Funobactam is an investigational new drug that is being evaluated for the treatment of hospital-acquired bacterial pneumonia. It is a β-lactamase inhibitor.
Wikipedia contributors, "Funobactam", Wikipedia, revision 1385109989, retrieved 20 November 2026, source, CC BY-SA 4.0.